Carlo Incerti, MD, SVP, Head Global Medical Affairs, Genzyme Corporation joined us last year at the World Orphan Drug Congress Europe to present on ‘Multi-Stakeholder Alignment: Unifying Efforts to Optimize Clinical Development and Establish a Harmonized and Accelerated Market Authorization Process’
Download this presentation now to find out more about:
- Inconsistent messaging
- Challenges for rare diseases
- Need for a strong healthcare ecosystem
- Understand stakeholders needs
- Where the obstacles are…
- Recipe for success
…And much more!
If you are interested in finding out more about multi-stakeholder relationships, then join us at the 5th Annual World Orphan Drug Congress.